MP
Martin Pfister
Venture Capital Investor at High-Tech Gründerfonds
Bonn, North Rhine-Westphalia
Overview
Martin Pfister is a VC investor specializing in lifesciences, a startup founder, and a scientist with a background in strategic consulting, entrepreneurship, and business development. Currently serving as a Venture Capital Investor at High-Tech Gründerfonds, he has made significant investments in companies like GeneQuine Biotherapeutics (Series A) and OMEICOS Therapeutics (Series C), showcasing his expertise in the pharmaceuticals, biotech, and digital health sectors.
Work Experience
Venture Capital Investor
2010 - Current
Principal (procurist, PoA), portfolio of 13 Lifescience startups in Biotech, Pharma, Medtech, digitalHealth and Dx, advisory board member in 5 portfolio companies
Supervisory Board Member
2022
Member Board of Directors
2020
Board of Directors (observer)
2020
Board of Directors (Observer)
2015
Board of Directors (observer)
2021 - 2022
Member Board of Directors
2017 - 2021
EXit 2021
Member Board of Directors
2016 - 2020
Founder, Partner
2004 - 2018
Exit to The Economist in 2018
Managing Director
2007 - 2010